Dr Mas Ayu research interest focuses on mental health, substance abuse and psychopharmacology, especially the side effect of metabolic syndrome due to the treatment of schizophrenia. A recipient of several research grants, she has many collaborative research activities with University Malaya Centre of Addiction Sciences. Her recent project is Enhancing Quality and Longevity of Life of Malaysian B40 under Long Term Research Grant Scheme (LRGS). She also involved in another project for B40 - Coping to Live with COVID-19: The New Norm which was funded by WHO.   As a public health specialist in infectious disease and field epidemiologist, Dr Mas Ayu is the member of Malaysia One Health University Network (MyOHUN) which is part of USAID. She is active in activity related to One Health in Malaysia and Southeast Asia Region. Dr Mas Ayu also has research interest on communicable diseases mainly focusing on vector borne diseases like Chikungunya and Dengue Fever. She has research collaboration through Malaysia-Sweden Research Link with Umea University, working on the early warning system of dengue outbreak. Dr Mas Ayu attended the evidence-based medicine (EBM) practice workshop as training for trainer in Oxford University in 2008, funded by grants from the European Union. The international collaboration was together with Utrecht (UMCU), Centre for Evidence-Based Medicine (CEBM), University of Oxford, the Rumah Sakit Cipto Mangunkusumo (RSCM) Hospital, Jakarta and University of Malaya. She has conducted several EBM workshops together with other trainers. She also served as panel for The Malaysian Qualifications Agency (MQA), which is a statutory body in Malaysia to accredit academic programs provided by educational institutions providing post-secondary or higher education and facilitate the accreditation and articulation of qualifications.

Dr. Victor Hoe is a distinguished academic and Public Health Medicina Specialist with a focus on occupational and public health at the Universiti Malaya. As of 2025, he holds several key positions, including Professor and Head of the Department of Social and Preventive Medicine in the Faculty of Medicine and Editor-in-Chief, Medical Journal of Malaysia. He was also a Senate Member for the University of Malaya (2021-2024) and Head of the Occupational Health, Safety and Environmental Unit at Universiti Malaya Medical Centre (2018-2022). Dr. Hoe's academic journey includes a PhD in Occupational Health and Safety from Monash University, Australia, and multiple master's degrees in public health and occupational safety, including Master of Engineering (Safety, Health and Environment) from UM and Master of Occupational Health from University of Turin. He is a Fellow of both the Academy of Medicine Malaysia (AMM) and the Academy of Occupational and Environmental Medicine Malaysia (AOEMM). Throughout his career, Professor Hoe has made significant contributions to the field of occupational and public health. He has been actively involved in various professional organisations, serving on national and international public health bodies. His research interests encompass worksite wellness, musculoskeletal disorders, ergonomics, and health risk assessment. Professor Hoe has been recognised with numerous awards, including the International Commission on Occupational Health's ILO Master Fellowship, and the Malaysian Medical Association’s Meritorious Award and Asia-Pacific Academic Consortium of Public Health’s Medal of Merit Award in 2023. He has been at the forefront of integrating technology into medical education and practice, and has played a crucial role in public health communication, particularly during the COVID-19 pandemic. As of 2025, Professor Hoe continues to lead important research projects, supervise doctoral and master's students, and contribute to national and international public health initiatives. His work remains crucial in advancing occupational and public health practices, policies, and education in Malaysia and the broader Asia-Pacific region.

Dr. Woo is a consultant gynaecological oncologist with clinical and research experience that ranges from prevention to treatment of cervical cancer and hereditary/ familial gynaecological cancers. She undertook her research in HPV immune-biology in the University of Cambridge under the Cancer Research UK Gordon Hamilton Fairley Fellowship and was awarded a PhD degree in 2008. As a clinician, she was awarded the gold medal by the Royal College of Obstetrician and Gynaecologist as the top ranked individual for the international examination. Having trained and worked in the UK, she returned to Malaysia in 2010 to take up a professorial post in the premier teaching hospital, University Malaya (UM). As a translational scientist, she has worked tirelessly to making this knowledge more accessible and applicable to the broader population through her advisory role on policy development nationally and internationally. She is also a recognized expert in HPV vaccination and is currently the country representative (Malaysia) for the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN), taskforce member for the Malaysian policy change to Primary HPV screening for cervical cancer, member of the Asia Pacific Economic Consortium (APEC) Cervical Cancer working group and is the founding principal investigator for Program ROSE (Removing Obstacles to cervical ScrEening, a revolutionary approach to cervical cancer screening. Program ROSE (www.programrose.org, @programROSE) that utilizes digital technology, self-sampling and HPV testing. The program was recently highlighted by the Economist Intelligence Unit (https://eiuperspectives.economist.com/healthcare/global-action-financing-cervical-cancer-elimination-funding-secondary-prevention-services-low). The program was a strong contender at the 2018 UICC Collaborative award, shortlisted among 2 other nominations globally, and has received many international accolades and praises. Program ROSE (www.programrose.org, @programROSE) utilizes digital technology, self-sampling and HPV testing to change the paradigm of conventional cervical screening, facilitating increased screening uptake for ALL woman. Dr Woo is also the founder of ROSE Foundation, a non-profit organisation, dedicated to making cervical cancer prevention accessible and affordable to the underprivileged. The success of Program ROSE is a testament to her incessant drive to make cervical cancer a rare disease in our lifetime. She also dedicates her time to working closely with other academic institutions, NGOS and also industry to educate, inform and advise on matters pertaining to control of HPV associated diseases. In recognition for her contribution to women's health, Dr. Woo was conferred the FIGO Awards in recognition of Female Obstetrician and Gynaecologist in 2021.